Harm reduction approaches to reducing tobacco-related mortality

被引:73
作者
Hatsukami, DK [1 ]
Henningfield, JE
Kotlyar, M
机构
[1] Univ Minnesota, Tobacco Use Res Ctr, Minneapolis, MN 55414 USA
[2] Pinney Associates, Bethesda, MD 20814 USA
[3] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA
关键词
reduced risk; reduced exposure products; harm reduction;
D O I
10.1146/annurev.publhealth.25.102802.124406
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Tobacco harm reduction approaches are gaining increased attention. Much of this attention is due to a growing concern that significant populations of smokers either do not want to quit or believe they are unable to quit smoking, and to a concern over tobacco-industry attempts to produce tobacco products that claim to result in less toxin exposure. Decreasing tobacco toxin exposure as a method for reducing mortality and morbidity may be a reasonable tobacco control strategy. However, the impact of this strategy must be explored both on individual and population levels. A significant amount of independent research is needed to inform policy decisions. Regulatory authority over potential reduced exposure products is also essential.
引用
收藏
页码:377 / 395
页数:19
相关论文
共 87 条
[1]  
[Anonymous], NIH PUBL
[2]  
[Anonymous], 2002, NICOTINE TOB RES S, DOI DOI 10.1080/1462220021000032780
[3]  
[Anonymous], 1988, HLTH CONS SMOK NIC A
[4]  
[Anonymous], 1994, ADDICTION BIOL DRUG
[5]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[6]   ESTABLISHING A NICOTINE THRESHOLD FOR ADDICTION - THE IMPLICATIONS FOR TOBACCO REGULATION [J].
BENOWITZ, NL ;
HENNINGFIELD, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (02) :123-125
[7]  
Bolliger Chris T, 2002, Nicotine Tob Res, V4, P433, DOI 10.1080/1462220021000018380
[8]   Smoking reduction with oral nicotine inhalers:: double blind, randomised clinical trial of efficacy and safety [J].
Bolliger, CT ;
Zellweger, JP ;
Danielsson, T ;
van Biljon, X ;
Robidou, A ;
Westin, Å ;
Perruchoud, AP ;
Säwe, U .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7257) :329-333
[9]   Chemical and biological studies of a new cigarette that primarily heats tobacco.: Part 3.: In vitro toxicity of whole smoke [J].
Bombick, DW ;
Ayres, PH ;
Putnam, K ;
Bombick, BR ;
Doolittle, DJ .
FOOD AND CHEMICAL TOXICOLOGY, 1998, 36 (03) :191-197
[10]  
Borm PYA, 2000, INHAL TOXICOL, V12, P1, DOI 10.1080/08958370050029725